Sign Out
Hypersensitivity to tinzaparin, heparin or constituents of Tinzaparin sodium (innohep) (e.g. sodium metabisulfite); current or history of heparin-associated thrombocytopenia (type II); uncontrolled severe hypertension; septic endocarditis; intracranial or intraocular bleeding or other current active bleeding process; haemorrhagic diathesis (inherited or acquired), deficiency of coagulation factors, severe thrombocytopenia; severe impairment of liver or pancreas; active gastric and/or duodenal ulcer disease; surgery involving the brain, spinal cord or eye; lumbar puncture, spinal or epidural anaesthesia; haemorrhagic stroke, cerebral aneurysm; retinopathy, vitreous haemorrhage; in women with abortus imminens.
For vials only: Because of its content of benzyl alcohol, this formulation is contraindicated in newborns.
Continue with Google